Article Details
Retrieved on: 2021-09-02 09:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
This monoclonal antibody [mAb] was initially developed on a traditional mammalian cell manufacturing platform but iBio plans to optimize and manufacture RTX-003 ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here